Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Antioxidants and Redox Signaling Année : 2012

Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.

Résumé

AIMS: Carbon monoxide (CO) delivered in a controlled manner to cells and organisms mediates a variety of pharmacological effects to the extent that CO-releasing molecules (CO-RMs) are being developed for therapeutic purposes. Recently, ruthenium-based CO-RMs have been shown to posses important bactericidal activity. Here we assessed the effect of fast CO releasers containing ruthenium (Ru(CO)(3)Cl(glycinate) [CORM-3] and tricarbonyldichlororuthenium(II) dimer [CORM-2]) and a novel slow manganese-based CO releaser ([Me(4)N][Mn(CO)(4)(thioacetate)(2)] [CORM-371]) on O(2) consumption and growth of Pseudomonas aeruginosa (PAO1). We then compared these effects with the action elicited by sodium boranocarbonate (CORM-A1), which lacks a transition metal but liberates CO with a rate similar to CORM-371. RESULTS: CORM-2, CORM-3, and, to a lesser extent, CORM-371 exerted a significant bactericidal effect and decreased O(2) consumption in PAO1 in vitro. The effect appeared to be independent of reactive oxygen species production, but in the case of metal-containing compounds it was prevented by the thiol donor N-acetylcysteine. In contrast, CORM-A1 was bacteriostatic rather than bactericidal in vitro eliciting only a moderate and transient decrease in O(2) consumption. INNOVATION: None of the tested CO-RMs was toxic to murine macrophages or human fibroblasts at the concentration impairing PA01 growth but only ruthenium-containing CO-RMs showed potential therapeutic properties by increasing the survival of mice infected with PA01. CONCLUSION: CO carriers inhibit bacterial growth and O(2) consumption in vitro, but transition metal carbonyls appear more powerful than compounds spontaneously liberating CO. The nature of the metal in CO-RMs also modulates the anti-bacterial effect, with ruthenium-based CO-RMs being efficacious both in vitro and in vivo.
Fichier principal
Vignette du fichier
ars.2011.pdf (1.38 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-00656413 , version 1 (04-01-2012)

Identifiants

Citer

Mathieu Desmard, Roberta Foresti, Didier Morin, Maylis Dagoussat, Alain Berdeaux, et al.. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.. Antioxidants and Redox Signaling, 2012, 16 (2), pp.153-63. ⟨10.1089/ars.2011.3959⟩. ⟨inserm-00656413⟩
177 Consultations
632 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More